Schedule 13G ownership disclosure
ARCA BIOPHARMA INC
Security class unavailable · CUSIP: 00211Y407
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 36,068
- Percent of class
- 2.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-006493
- Form type
- SC 13G
- Filer
- Oruka Therapeutics, Inc.
- CIK
- CIK 907654
- Filed
- Jan 24, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership